Literature DB >> 28481057

Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjects.

Devyani Lal1, Paul Keim2,3,4, Josie Delisle2, Bridget Barker2,3, Matthew A Rank5, Nicholas Chia6, James M Schupp2, John D Gillece2, Emily K Cope2,3,4.   

Abstract

BACKGROUND: The role of microbiota in sinonasal inflammation can be further understood by targeted sampling of healthy and diseased subjects. We compared the microbiota of the middle meatus (MM) and inferior meatus (IM) in healthy, allergic rhinitis (AR), and chronic rhinosinusitis (CRS) subjects to characterize intrasubject, intersubject, and intergroup differences.
METHODS: Subjects were recruited in the office, and characterized into healthy, AR, and CRS groups. Endoscopically-guided swab samples were obtained from the MM and IM bilaterally. Bacterial microbiota were characterized by sequencing the V3-V4 region of the 16S ribosomal RNA (rRNA) gene.
RESULTS: Intersubject microbiome analyses were conducted in 65 subjects: 8 healthy, 11 AR, and 46 CRS (25 CRS with nasal polyps [CRSwNP]; 21 CRS without nasal polyps [CRSsNP]). Intrasubject analyses were conducted for 48 individuals (4 controls, 11 AR, 8 CRSwNP, and 15 CRSwNP). There was considerable intersubject microbiota variability, but intrasubject profiles were similar (p = 0.001, nonparametric t test). Intrasubject bacterial diversity was significantly reduced in MM of CRSsNP subjects compared to IM samples (p = 0.022, nonparametric t test). CRSsNP MM samples were enriched in Streptococcus, Haemophilus, and Fusobacterium spp. but exhibited loss of diversity compared to healthy, CRSwNP, and AR subject-samples (p < 0.05; nonparametric t test). CRSwNP patients were enriched in Staphylococcus, Alloiococcus, and Corynebacterium spp.
CONCLUSION: This study presents the sinonasal microbiome profile in one of the larger populations of non-CRS and CRS subjects, and is the first office-based cohort in the literature. In contrast to healthy, AR, and CRSwNP subjects, CRSsNP MM samples exhibited decreased microbiome diversity and anaerobic enrichment. CRSsNP MM samples had reduced diversity compared to same-subject IM samples, a novel finding.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  allergic rhinitis; bacteriology; chronic rhinosinusitis; inferior meatus; microbioata; microbiome; middle meatus; nasal polyposis; regional sinonasal microbiota and rhinosinusitis

Mesh:

Substances:

Year:  2017        PMID: 28481057     DOI: 10.1002/alr.21934

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  29 in total

1.  Comparing the nasal bacterial microbiome diversity of allergic rhinitis, chronic rhinosinusitis and control subjects.

Authors:  Weigang Gan; Fengjuan Yang; Juan Meng; Feng Liu; Shixi Liu; Junming Xian
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-28       Impact factor: 2.503

Review 2.  Unraveling the role of the microbiome in chronic rhinosinusitis.

Authors:  Alkis J Psaltis; Brett Wagner Mackenzie; Emily K Cope; Vijay R Ramakrishnan
Journal:  J Allergy Clin Immunol       Date:  2022-03-14       Impact factor: 14.290

3.  The nasal microbiome in patients with chronic rhinosinusitis: Analyzing the effects of atopy and bacterial functional pathways in 111 patients.

Authors:  Mahboobeh Mahdavinia; Phillip A Engen; Phillip S LoSavio; Ankur Naqib; Rafsa J Khan; Mary C Tobin; Arpita Mehta; Raj Kota; Nailliw Z Preite; Christopher D Codispoti; Bobby A Tajudeen; Robert P Schleimer; Stefan J Green; Ali Keshavarzian; Pete S Batra
Journal:  J Allergy Clin Immunol       Date:  2018-02-13       Impact factor: 10.793

4.  Fungal Microbiota in Chronic Airway Inflammatory Disease and Emerging Relationships with the Host Immune Response.

Authors:  Irene Zhang; Steven D Pletcher; Andrew N Goldberg; Bridget M Barker; Emily K Cope
Journal:  Front Microbiol       Date:  2017-12-12       Impact factor: 5.640

Review 5.  Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis.

Authors:  Rohit Divekar; Devyani Lal
Journal:  F1000Res       Date:  2018-03-29

6.  Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population.

Authors:  Giulia Brindisi; Anna Maria Zicari; Laura Schiavi; Alessandra Gori; Maria Pia Conte; Massimiliano Marazzato; Giovanna De Castro; Lucia Leonardi; Marzia Duse
Journal:  Ital J Pediatr       Date:  2020-07-07       Impact factor: 2.638

7.  Association of the sinonasal bacterial microbiome with clinical outcomes in chronic rhinosinusitis: a systematic review.

Authors:  James C Wang; Charles A Moore; Madison V Epperson; Ahmad R Sedaghat
Journal:  Int Forum Allergy Rhinol       Date:  2020-02-13       Impact factor: 5.426

8.  Host-Microbe Interactions in Airway Disease: toward Disease Mechanisms and Novel Therapeutic Strategies.

Authors:  Emily K Cope
Journal:  mSystems       Date:  2018-03-13       Impact factor: 6.496

9.  Microbiome and Culture Based Analysis of Chronic Rhinosinusitis Compared to Healthy Sinus Mucosa.

Authors:  Kerstin Koeller; Daniel P R Herlemann; Tobias Schuldt; Attila Ovari; Ellen Guder; Andreas Podbielski; Bernd Kreikemeyer; Bernhard Olzowy
Journal:  Front Microbiol       Date:  2018-04-17       Impact factor: 5.640

Review 10.  Microbiota Composition and the Integration of Exogenous and Endogenous Signals in Reactive Nasal Inflammation.

Authors:  Francesco Antonio Salzano; Luigi Marino; Giovanni Salzano; Riccardo Maria Botta; Giovanni Cascone; Umberto D'Agostino Fiorenza; Carmine Selleri; Vincenzo Casolaro
Journal:  J Immunol Res       Date:  2018-06-03       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.